Results 31 to 40 of about 179,854 (236)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study

PLoS ONE, 2023
The prevalence of substandard and falsified medicines in low- and middle-income countries (LMICs) is a major global public health concern. Multiple screening technologies for post-market surveillance of medicine quality have been developed but there ...
Colleen R. Higgins, Betty Kobia, Sachiko Ozawa   +2 more
doaj   +2 more sources

Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries

Frontiers in Medicine, 2022
IntroductionThe presence of N-nitrosamine impurities in medicines raised concerns globally as they are genotoxic and probable human carcinogens. A review of N-nitrosamine impurities in medicines provides an opportunity for National Regulatory Authorities
Patience P. Shabangu, Rutendo J. Kuwana, Admire Dube   +2 more
doaj   +1 more source

Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites. [PDF]

Drug Saf, 2015
Background Substandard medicines, whether the result of intentional manipulation or lack of compliance with good manufacturing practice (GMP) or good distribution practice (GDP), pose a significant potential threat to patient safety.
Juhlin K, Karimi G, Andér M, Camilli S, Dheda M, Har TS, Isahak R, Lee SJ, Vaughan S, Caduff P, Norén GN.   +10 more
europepmc   +2 more sources

Substandard and/or counterfeit medicines for patients

Bulletin of the World Health Organization, 2007
Subhash C Arya, Nirmala Agarwal
doaj   +1 more source

Counterfeit Healthcare Products: Nepal at a Vulnerable Position

Journal of Nepal Medical Association, 2022
Nepal stands in a vulnerable position when it comes to counterfeit medicines as two of its major trade partners countries are leading producers of falsified healthcare products. The impacts that it can lead to are a lower standard of healthcare delivery
Bijay Bhandari, Gaurav Rayamajhi
doaj   +1 more source

Guidelines for field surveys of the quality of medicines: a proposal. [PDF]

, 2009
Paul Newton and colleagues propose guidelines for conducting and reporting field surveys of the quality of ...
Catherine Goodman, Lisa J White, Harparkash Kaur, Amin, AA, Souly Phanouvong, Paul N Newton, Kokwaro, Gilbert O, Shunmay Yeung, Newton, Paul N., Lukulay, P, Green, Michael D, Phanouvong, S, White, Lisa, Facundo M Fernández, Patrick Lukulay, Amin Abdinasir A, Lindegårdh Niklas, Yeung, Shunmay, Kaur Harparkash, Newton, Paul N, Whitty, CJ, Amin, Abdinasir A, Day, Nicholas PJ, Goodman Catherine, Fernández, Facundo M., Nicholas J White, Newton, PN, Goodman, Catherine, Whitty Christopher J. M, Lee, Sue J, Whitty, Christopher J. M., Lee Sue J, White Lisa J, Lee, Sue J., White, Nicholas, White, LJ, Michael D Green, Green Michael D, White, Nicholas J., Kokwaro, Gilbert O., Lee, Sue, Fernández, FM, Lindegårdh, N, Fernández, Facundo M, Kokwaro Gilbert O, Day, Nicholas P. J., White, Nicholas J, Whitty, Christopher JM, Day, NP, Nicholas P J Day, White, Lisa J., Newton Paul N, Kokwaro, GO, Yeung Shunmay, Yeung, S, Green, Michael D., White Nicholas J, Newton, Paul, Lukulay Patrick, Lee, SJ, Abdinasir A Amin, Phanouvong Souly, Phanouvong, Souly, Lindegårdh, Niklas, Fernández Facundo M, Christopher J M Whitty, Gilbert O Kokwaro, Lukulay, Patrick, Kaur, Harparkash, Day, Nicholas, Sue J Lee, Amin, Abdinasir A., Goodman, C, White, NJ, Day Nicholas P. J, Niklas Lindegårdh, Green, MD, White, Lisa J, Kaur, H   +78 more
core   +2 more sources

List of identified substandard medicines.

, 2023
Essential medicines are those medicines that satisfy the primary health care needs of the citizens. Poor quality of essential medicines can have serious impact on public health.
Neelam Dhakal (15909651), Baburam Humagain (15909654), Rajendra BC (15909657), Nisha Jha (3618995), Phoolgen Sah (15909660), Anjani Kumar Jha (10281830), Amita Pradhan (4625509), Pradip Gyanwali (11210433), Meghnath Dhimal (595091)   +8 more
core   +1 more source

Quality of antimalarial drugs and antibiotics in Papua New Guinea : a survey of the health facility supply chain [PDF]

, 2014
Poor-quality life-saving medicines are a major public health threat, particularly in settings with a weak regulatory environment. Insufficient amounts of active pharmaceutical ingredients (API) endanger patient safety and may contribute to the ...
Betuela Inoni, Davis, T., Page-Sharp Madhu, Betuela, I., Page-Sharp, Madhu, Bala, Nancy, Bala Nancy, Manuel W Hetzel, Timothy M E Davis, Evelyn K Lavu, Pulford Justin, Lavu, Evelyn K., Nancy Bala, Nancy Bala (563875), Hetzel Manuel W., Davis Timothy M. E., Madhu Page-Sharp (563874), Evelyn K. Lavu (563877), Davis, Timothy M. E., Lavu Evelyn K., Justin Pulford, Lavu, E., Bala, N., Pulford, J., Madhu Page-Sharp, Betuela, Inoni, Inoni Betuela, Hetzel, M., Hetzel, Manuel W., Pulford, Justin, Justin Pulford (563876), Inoni Betuela (67110), Timothy M. E. Davis (112260), Manuel W. Hetzel (563873)   +33 more
core   +2 more sources

Rapid Screening Methods to Identify Substandard and Falsified Medicines [PDF]

, 2018
Substandard and falsified medicines (SF) are a major global public health problem and occur throughout healthcare systems worldwide. With an average occurrence of 10% of all medicines globally, the specific levels range from ~1% of all medicines in high ...
Armitage, R.
core   +7 more sources

Medicine quality in high-income countries: The obstacles to comparative prevalence studies

Medicine Access @ Point of Care, 2021
The entry of falsified and substandard medicines into the legitimate pharmaceutical supply chain has negative impacts on healthcare systems, patient safety, and patient access to medicine. The COVID-19 pandemic has highlighted the importance of access to
Bernard David Naughton, Ebru Akgul
doaj   +1 more source